Not Signed In -
Epoprostenol |
Flolan |
Prostacyclin Systematic (IUPAC) name 5-[7-hydroxy-8- (3-hydroxyoct-1-enyl) -4-oxabicyclo[3.3.0]oct-3-ylidene] pentanoic acid Identifiers CAS number 35121-78-9 ATC code B01AC09 PubChem 114805 DrugBank APRD00949 Chemical data Formula C20H32O5 Mol. weight 352.465 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life ? Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Prostac ...
Wikipedia - [full article]
Epoprostenol Clinical Trials
- Open Label Extension Study Evaluating Sildenafil Citrate When Used In Combination with Epoprostenol In PAH
ClinicalTrials.gov Identifier: NCT00147641 - Active, not recruiting
Pulmonary Hypertension
- Safety, Efficacy and Treatment Satisfaction in Patients With Pulmonary Arterial Hypertension Rapidly Switched From Epoprostenol to Remodulin
ClinicalTrials.gov Identifier: NCT00373360 - Recruiting
Pulmonary Hypertension
- Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
ClinicalTrials.gov Identifier: NCT00004754 - Completed
Hypertension, Pulmonary
- The Efficacy and Safety of Sildenafil Citrate Used in Combination with Intravenous Epoprostenol in PAH
ClinicalTrials.gov Identifier: NCT00159861 - Completed
Pulmonary Hypertension
Resources
- Epoprostenol (Drug Digest)
- Flolan (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
